Caveat User, Caveat Emptor - Issues from the Soft Under Belly of The CMS Data Sets

Mark Labovitz, Ph.D., MBA

August 2, 2016

While the goals of Open Payments and transparency are arguably good public policy, the usefulness of Open Payments depends entirely on the quality of the underlying data. This paper explores some of challenges found in the 2015 data set that negatively impact that usefulness.

Labovitz, M. 2016. Caveat User, Caveat Emptor - Issues from the Soft Under Belly of The CMS Data Sets. Life Science Compliance Update, U.S. EDITION, Volume 2.8, August 2016. pp. 5-10.

Blog Articles

Caveat User, Caveat Emptor - Issues from the Soft Under Belly of The CMS Data Sets
Read More >

Detecting the "Sham" in Speaker Programs
Read More >

“Open Payments – A New Source of Clinical Site Intelligence”
Read More >

Workshop Speaker, "Demonstrating Compliance to the Department of Justice"
Read More >

Coauthor, “Are Phase 3 Clinical Trials Really Becoming More Complex?”
Read More >

View All Company News >